We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0UI8 market cap is 6.15B. The company's latest EPS is USD -0.4528 and P/E is -147.08.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -29.11M | -26.86M | -55.77M | -65.45M | -42.6M |
Net Income | -28.87M | -26.28M | -55.24M | -65.35M | -41.82M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 16.87M | 100.48M | 126.26M | 82.53M | 51.03M |
Total Liabilities | 2.79M | 6.55M | 7.35M | 8.29M | 13.29M |
Total Equity | 14.08M | 93.93M | 118.92M | 74.24M | 37.74M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -23.21M | -21.56M | -33.89M | -43.3M | -32.32M |
Investing | 12k | -17.37M | 12.63M | -35.21M | 30.07M |
Financing | 27.87M | 103.45M | 58.81M | 226k | 116k |
Market Cap | 6.15B |
Price to Earnings Ratio | -147.08 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 166.42 |
Price to Book Ratio | 163 |
Dividend Yield | - |
Shares Outstanding | 92.37M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 3 |
52 Week Change | 0.00% |
52 Week High | 66.60 |
52 Week Low | 66.60 |
Spread (Intraday) | 0 (0%) |
Company Name | Aptose Biosciences Inc |
Address |
5955 airport road mississauga, ontario L4V 1R9 |
Website | https://www.aptose.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions